Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Antimicrobial Resistance and Serotypes in the Clinical Isolates of Group B Streptococci

Original article

Annals of Clinical Microbiology (Ann Clin Microbiol) 1999 June Volume 2, Issue 1, pages 64-70.

Antimicrobial Resistance and Serotypes in the Clinical Isolates of Group B Streptococci

Young Uh, M.D., In Ho Jang, M.D., Gyu Yel Hwang, M.D. and Kap Jun Yoon, M.D.

Department of Clinical Pathology, Yonsei University Wonju College of Medicine, Wonju, Korea

Abstract

Background:This study is designed to provide data on the trend of resistance by year of isolation in the clinical isolates of group B streptococci(GBS) during recent eight years and to elucidate the relationship between serotypes and antimicrobial resistance patterns.

Methods:The minimal inhibitory concentrations (MIC) of seven antimicrobial agents and serotypes for 150 strains of GBS isolated from clinical specimens between 1990 and 1997 were investigated.

Results:The resistance rate of 150 clinical isolates of GBS were 20.0% to clindamycin, 16.0% to erythromycin, 4.0% to chloramphenicol, and 95.3% to tetracycline. None was resistant to penicillin, ceftriaxone, or vancomycin. Of the 24 isolates resistant to erythromycin, 20 (83.3%) were resistant to clindamycin. Resistance rates of erythromycin according to serotypes in decreasing order were 69.2% (V), 23.2% (III), and 3.5% (Ib). All serotypes Ia and II were susceptible to erythromycin and clindamycin.

Conclusions:Striking emergence of resistant strains to erythromycin and clindamycin in our clinical isolates of GBS was mainly due to sudden increase of serotype V and III which shows multi-drug resistance phenotype. (Korean J Clin Microbiol 1999;2:64~70)

Keywords

Group B streptococci (GBS), Antimicrobial susceptibility, Erythromycin resistance, Clindamycin resistance, Serotype